137 related articles for article (PubMed ID: 11875317)
1. Nitric oxide and potassium channels are involved in brain natriuretic peptide induced vasodilatation in man.
van der Zander K; Houben AJ; Kroon AA; De Mey JG; Smits PA; de Leeuw PW
J Hypertens; 2002 Mar; 20(3):493-9. PubMed ID: 11875317
[TBL] [Abstract][Full Text] [Related]
2. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease.
Ozkor MA; Murrow JR; Rahman AM; Kavtaradze N; Lin J; Manatunga A; Quyyumi AA
Circulation; 2011 May; 123(20):2244-53. PubMed ID: 21555712
[TBL] [Abstract][Full Text] [Related]
4. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
[TBL] [Abstract][Full Text] [Related]
5. Relative contribution of vasodilator prostanoids, NO, and KATP channels to human forearm metabolic vasodilation.
Farouque HM; Meredith IT
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2405-11. PubMed ID: 12598235
[TBL] [Abstract][Full Text] [Related]
6. Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide.
van der Zander K; Houben AJ; Kroon AA; de Leeuw PW
Cardiovasc Res; 1999 Dec; 44(3):595-600. PubMed ID: 10690292
[TBL] [Abstract][Full Text] [Related]
7. Activation of the ATP-dependent potassium channel attenuates norepinephrine-induced vasoconstriction in the human forearm.
Pickkers P; Jansen Van Rosendaal AJ; Van Der Hoeven JG; Smits P
Shock; 2004 Oct; 22(4):320-5. PubMed ID: 15377886
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans.
de Hoon JN; Pickkers P; Smits P; Struijker-Boudier HA; Van Bortel LM
Clin Pharmacol Ther; 2003 Apr; 73(4):312-21. PubMed ID: 12709721
[TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels.
Honing ML; Smits P; Morrison PJ; Burnett JC; Rabelink TJ
Hypertension; 2001 Apr; 37(4):1179-83. PubMed ID: 11304521
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide in adenosine-induced vasodilation in humans.
Costa F; Biaggioni I
Hypertension; 1998 May; 31(5):1061-4. PubMed ID: 9576114
[TBL] [Abstract][Full Text] [Related]
11. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age.
Lyons D; Roy S; Patel M; Benjamin N; Swift CG
Clin Sci (Lond); 1997 Dec; 93(6):519-25. PubMed ID: 9497788
[TBL] [Abstract][Full Text] [Related]
12. Methodological validity and feasibility of the nitric oxide clamp technique for nitric oxide research in human resistant vessels.
Ueda S; Wada A; Umemura S
Hypertens Res; 2004 May; 27(5):351-7. PubMed ID: 15198483
[TBL] [Abstract][Full Text] [Related]
13. Relative significance of the nitric oxide (NO)/cGMP pathway and K+ channel activation in endothelium-dependent vasodilation in the femoral artery of developing piglets.
Støen R; Lossius K; Persson AA; Karlsson JO
Acta Physiol Scand; 2001 Jan; 171(1):29-35. PubMed ID: 11350260
[TBL] [Abstract][Full Text] [Related]
14. Effects of exogenous and endogenous natriuretic peptides on forearm vascular function in chronic heart failure.
Schmitt M; Gunaruwan P; Payne N; Taylor J; Lee L; Broadley AJ; Nightingale AK; Cockcroft JR; Struthers AD; Tyberg JV; Frenneaux MP
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):911-7. PubMed ID: 15001459
[TBL] [Abstract][Full Text] [Related]
15. Is nitric oxide involved in cutaneous vasodilation during body heating in humans?
Dietz NM; Rivera JM; Warner DO; Joyner MJ
J Appl Physiol (1985); 1994 May; 76(5):2047-53. PubMed ID: 7520431
[TBL] [Abstract][Full Text] [Related]
16. Ischaemia enhances the role of Ca2+-activated K+ channels in endothelium-dependent and nitric oxide-mediated dilatation of the rat hindquarters vasculature.
Woodman OL; Wongsawatkul O
Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):254-60. PubMed ID: 15053823
[TBL] [Abstract][Full Text] [Related]
17. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension.
Calver A; Collier J; Vallance P
Cardiovasc Res; 1994 Nov; 28(11):1720-5. PubMed ID: 7531114
[TBL] [Abstract][Full Text] [Related]
18. NG-monomethyl-L-ARG reduces the forearm vasodilator response to acetylcholine but not to methacholine in humans.
Rongen GA; Smits P; Thien T
J Cardiovasc Pharmacol; 1993 Dec; 22(6):884-8. PubMed ID: 7509909
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Hypertension; 1997 Jan; 29(1 Pt 2):274-9. PubMed ID: 9039114
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandins are involved in acetylcholine- and 5-hydroxytryptamine-induced, nitric oxide-mediated vasodilatation in human forearm.
Kamper AM; Paul LC; Blauw GJ
J Cardiovasc Pharmacol; 2002 Dec; 40(6):922-9. PubMed ID: 12451326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
